Publication | Closed Access

Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial

ObesityMetabolic SyndromeDose-finding Phase 2Non-pharmacological InterventionLifestyle ModificationClinical TrialsWeight ManagementObesity ManagementRandomized Controlled TrialOnce-weekly CagrilintidePharmacotherapyMedicineHealth Sciences